Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis | Thrombosis Journal | Full Text
Table 3 from Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management | Semantic Scholar
Comparison of upper gastrointestinal bleeding risk in users of warfarin... | Download Scientific Diagram
Non-variceal upper gastrointestinal bleeding | Nature Reviews Disease Primers
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases | Journal of Thrombosis and Thrombolysis
IJMS | Free Full-Text | Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors∗ | Journal of the American College of Cardiology
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library
Frontiers | Effectiveness and safety of oral anticoagulant therapy in patients with atrial fibrillation with prior gastrointestinal bleeding: A systematic review and meta-analysis
figure50_large.png
Major bleeding, intracranial hemorrhage and gastrointestinal bleeding.... | Download Scientific Diagram
IJERPH | Free Full-Text | The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis
Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea - Han - 2021 - Journal of Arrhythmia - Wiley Online Library
![PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bab146b6bd233e87b294e36dd37d4d71fd77713/7-Table3-1.png "PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar")
PDF] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial. | Semantic Scholar
Challenging Cases – Upper GI Bleeding on Anticoagulants and Antiplatelets - BroadcastMed
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer - ScienceDirect
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight | Journal of the American College of Cardiology
Bleeding outcomes. A) Major bleeding: All four new oral anticoagulants... | Download Scientific Diagram
Reversal Agent vs Supportive Care for NOAC-Related Bleeds: What Do the Data Suggest? (Transcript)
figure23_large.png
Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences | The Egyptian Heart Journal | Full
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation | Circulation: Cardiovascular Quality and Outcomes
Meta-analysis of large NOAC trials shows favourable risk/benefit ratio over warfarin - PACE-CME
Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation | Journal of Managed Care & Specialty Pharmacy
